Health-related quality of life in patients with lung cancer



Research Article        Open-Access Publishing | Gitter-Smolarz Library of <br>Life Sciences and  Medicine | Tel Aviv University

American Journal of BioMedicine
Volume 11, Issue 4, 2023, Pages 165-171      10.18081/2333-5106/2023.11/165

Libo Han 1 , Ri Li 1 , Xia Wang *

Received 23 May 2023; revised 04 August 2023; accepted 06 September 2023; published 21 October 2023


Abstract

Lung cancer has been the most common type of cancer worldwide for several decades. 55 patients treated for lung cancer with a mean age of 60.9±4.2 evaluated through Health-related QoL (HRQoL) were assessed individually using the valid and reliable questionnaires Cancer Quality of Life EORTC (QLQ) - C30 and QLQ - H&N35.  The functioning scale in the QLQ-C30 questionnaire with the lowest average score was global health status. The mean QLQ-C30 summary score (77.17 ± 11.4). The symptoms with the highest scores were dyspnea, weight loss, and muscle atrophy. Linear regression analysis demonstrated that Global health status score was associated with education level [β-coefficient = 15.21 (95% CI: 10.2-21.9, P=0.01], alcohol consumption [β-coefficient=11.02 (95% CI: 5.3-16.3), P=0.01]. In conclusion. This study demonstrated several predictors of worse perception of HRQoL through study. Moreover, these predictors should be the focus of preventive measurements, early detection of lung cancer, and target therapy.

Keywords: Lung cancer; QLQ-C30; QLQ - H&N35

Copyright © 2023 Wang, et al. This article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Cited by other articlesReferencesStatistics
The citation data is computed by the following citation measuring services:Google Scholar
Cited by CrossRef (0)
Cited by Scopus ()

1. Walters S. Benitez-Majano S. Muller P, et al. Is England closing the international gap in cancer survival? Br J Cancer. 2015; 113:848-60.
https://doi.org/10.1038/bjc.2015.265
2. Tanvetyanon T. Robinson LA. Schell MJ, et al. Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis. J Clin Oncol. 2008; 26:1142-7.
https://doi.org/10.1200/JCO.2007.14.2091
3. Office for National Statistics Cancer survival by stage at diagnosis for England (experimental statistics): Adults diagnosed 2012, 2013 and 2014 and followed up to 2015. 2016. ONS.
4. Falcoz PE. Puyraveau M. Thomas PA, et al. Video-assisted thoracoscopic surgery versus open lobectomy for primary non-small-cell lung cancer: a propensity-matched analysis of outcome from the European Society of Thoracic Surgeon database. Eur J Cardiothorac Surg. 2016; 49:602-9.
https://doi.org/10.1093/ejcts/ezv154
5. Riaz SP. Linklater KM. Page R, et al. Recent trends in resection rates among non-small cell lung cancer patients in England. Thorax. 2012; 67:811-14.
https://doi.org/10.1136/thoraxjnl-2012-201768
6. Ferrell BR. Temel JS. Temin S, et al. Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2017; 35:96-112.
https://doi.org/10.1200/JCO.2016.70.1474
7. Cancer Research UK. Lung cancer diagnosis and treatment statistics. Cancer Research UK, 2016.
8. O'Dowd EL, McKeever TM, Baldwin DR, et al. What characteristics of primary care and patients are associated with early death in patients with lung cancer in the UK? Thorax. 2015; 70:161-8.
https://doi.org/10.1136/thoraxjnl-2014-205692
9. Goldstraw P, Chansky K, Crowley J, et al. The IASLC Lung Cancer Staging Project: Proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol. 2016; 11:39-51.
https://doi.org/10.1016/j.jtho.2015.09.009
10. Fayers PM, Aaronson NK, Bjordal K, et al. The EORTC QLQ-C30 Scoring Manual (3rdEdi-tion). European Organisation for Research and Treatment of Cancer, Brussels 2001.
11. Husson O, de Rooij BH, Kieffer J, et al. The EORTC QLQ-C30 Summary Score as Prognostic Factor for Survival of Patients with Cancer in the "Real-World": Results from the Population-Based PROFILES Registry. Oncologist. 2020; 25(4):e722-e732.
https://doi.org/10.1634/theoncologist.2019-0348
12. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Re-search and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1998; 85(5): 365-76.
https://doi.org/10.1093/jnci/85.5.365
13. Chua IS, Zachariah F, Dale W, et al. Early integrated telehealth versus in-person palliative care for patients with advanced lung cancer: A study protocol. J Palliat Med. 2019; 22:S-7.
https://doi.org/10.1089/jpm.2019.0210
14. Cella DF, Bonomi AE, Lloyd SR, et al. Reliability and validity of the functional assessment of cancer therapy-lung (FACT-L) quality of life instrument. Lung Cancer. 1995; 12:199-220.
https://doi.org/10.1016/0169-5002(95)00450-F
15. Dharma-Wardene M, Au H-J, Hanson J, et al. Baseline FACT-G score is a predictor of survival for advanced lung cancer. Qual Life Res. 2004; 13:1209-1216.
https://doi.org/10.1023/B:QURE.0000037481.36604.eb
16. Eton DT, Cella D, Yost KJ, et al. A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale. J Clin Epidemiol. 2004; 57:898-910.
https://doi.org/10.1016/j.jclinepi.2004.01.012
17. Kroenke K, Spitzer RL, and Williams JBW: The PHQ-9. J Gen Intern Med. 2001; 16:606-613.
https://doi.org/10.1046/j.1525-1497.2001.016009606.x
18. Dionne-Odom JN, Hull JG, Martin MY, et al. Associations between advanced cancer patients' survival and family caregiver presence and burden. Cancer Med. 2016; 5:853-862.
https://doi.org/10.1002/cam4.653
19. Courtin E and Knapp M. Social isolation, loneliness and health in old age: A scoping review. Health Soc Care Commun. 2017; 25:799-812.
https://doi.org/10.1111/hsc.12311
20. Holt-Lunstad J, Smith TB, Baker M, et al. Loneliness and social isolation as risk factors for mortality: A meta-analytic review. Perspect Psychol Sci. 2015; 10:227-237.
https://doi.org/10.1177/1745691614568352
21. Helgeson VS. Social support and quality of life. Qual Life Res. 2003; 12(Suppl 1):25-31.
https://doi.org/10.1023/A:1023509117524
22. Katschnig H, Freeman H, Sartorius N. Quality of Life in Mental Disorders. 2nd edn New York: Wiley, 2005.
https://doi.org/10.1345/aph.1G684
23. Mohammed GK, Mohammed SM, Hadi NR, et al. Association between Natural Killer Cell Cytotoxicity and the Progression of Non-Small Cell Lung Cancer. Sys Rev Pharm. 2020; 11(4): 543-551.
https://doi.org/10.31838/srp.2020.4.81
24. Hsu YH, Chai HY, Lin YF, et al. Health-related quality of life and satisfaction with case management in cancer survivors. J Clin Nurs. 2017; 26:4597-604.
https://doi.org/10.1111/jocn.13805
25. Pergolotti M, Deal AM, Williams GR, et al. Activities, function, and health-related quality of life (HRQOL) of older adults with cancer. J Geriatr Oncol. 2017; 8:249-54.
https://doi.org/10.1016/j.jgo.2017.02.009
26. McCarberg BH, Nicholson BD, Todd KH, et al. The impact of pain on quality of life and the unmet needs of pain management: results from pain sufferers and physicians participating in an Internet survey. Am J Ther. 2008; 15:312-20.
https://doi.org/10.1097/MJT.0b013e31818164f2
27. Salomaa ER, Sällinen S, Hiekkanen H, et al. Delays in the diagnosis and treatment of lung cancer. Chest. 2005; 128:2282-8.
https://doi.org/10.1378/chest.128.4.2282
28. Montazeri A, Hole DJ, Milroy R, et al. Quality of life in lung cancer patients: does socioeconomic status matter? Health Qual Life Outcomes. 2003; 1:19.
https://doi.org/10.1186/1477-7525-1-19
29. Myrdal G, Valtysdottir S, Lambe M, et al. Quality of life following lung cancer surgery. Thorax. 2003; 58:194-7.
https://doi.org/10.1136/thorax.58.3.194
30. Lee LJ, Chung CW, Chang YY, et al. Comparison of the quality of life between patients with non-small-cell lung cancer and healthy controls. Qual Life Res. 2011; 20:415-23.
https://doi.org/10.1007/s11136-010-9761-y
31. Xia P, Li N, Hau KT, et al. Quality of life of Chinese urban community residents: a psychometric study of the mainland Chinese version of the WHOQOL-BREF. BMC Med Res Methodol. 2012; 12:37.
https://doi.org/10.1186/1471-2288-12-37
32. Lencioni R. Crocetti L. Cioni R, et al. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study) Lancet Oncol. 2008; 9:621-8.
https://doi.org/10.1016/S1470-2045(08)70155-4
33. Felip E, Sakai H, Patel J, et al. OA12.01 Phase II data for the MET inhibitor tepotinib in patients with advanced NSCLC and MET exon 14-skipping mutations. J Thorac Oncol. 2018; 13(10):S347.
https://doi.org/10.1016/j.jtho.2018.08.299
34. Hadi N, Lee J, Adrienne J, et al. Expression of IL-32 modulates NF-κB and p38 MAP kinase pathways in human esophageal cancer. Cytokine. 2014; 61(1):223-227.
https://doi.org/10.1016/j.cyto.2012.09.022

File and statistics

 

How to cite

Han L, Li R, Wang X. Health-related quality of life in patients with lung cancer. American Journal of BioMedicine 2023; 11(4):165-171.

More Citation

APA
American Journal of BioMedicine. (2023). American Journal of Biomedicine. https://doi.org/10.18081/2333-5106
MLA
Sambit Chandra; Sujeet D. Vijayakumar. “Laparoscopic ovarian electrocauterization in polycystic ovarian syndrome: outcome and Influencing factors”. American Journal of BioMedicine, 11, 1, 2023, 10-21. doi: 10.18081/2333-5106/2023.11/10
HARVARD
Chandra, S., Vijayakumar, V. (2023). Laparoscopic ovarian electrocauterization in polycystic ovarian syndrome: outcome and Influencing factors. American Journal of BioMedicine, 11(1), PP. 10-21.doi: 10.18081/2333-5106/2023.11/10
VANCOUVER
Abd AL-Hussein AJ, Abad Alruda GM, Yousif NG. Increased neutrophil-lymphocyte ratio in patients with COPD: case-control study . American Journal of BioMedicine 2023; 11(3):144-157

Article Metrics

Permissions

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All articles published in American Journal of BioMedicine  are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.